Skip to content
stoqly

Beyond Air, Inc.

XAIR Nasdaq Surgical & Medical Instruments & Apparatus Financials FY2017–FY2026

Revenue Total sales reported in the income statement.
$7.7M
107.3% vs prior year
Operating margin Operating income as a share of revenue.
βˆ’378.2%
823.9 pts
Net income Profit after all expenses, interest and tax.
βˆ’$33.2M
Free cash flow Cash from operations minus capital spending.
βˆ’$19.2M
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
β€”
Market cap Last close times the latest diluted share count, so it is approximate.
β€”
P/E Last close divided by diluted earnings per share over the last four quarters.
β€”
On $15.66 EPS (TTM)

What Beyond Air, Inc. does

No business description yet.

Legal name
Beyond Air, Inc.
Fiscal year ends
March 31, 2026
Latest annual report
10-K Β· Jun 26, 2026
Accession Β· CIK
0001493152-26-030287
0001641631

Revenue and margins

Beyond Air, Inc. had $7.7M of revenue in fiscal 2026, up 107.3% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was βˆ’$19.2M in fiscal 2026, βˆ’249.6% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Beyond Air, Inc. returned β€” to shareholders in fiscal 2026. The diluted share count rose 145.2%.

Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Beyond Air, Inc. can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY22FY23FY24FY25FY26
Cash and short-term investments $80.2M$45.9M$34.5M$6.9M$11.6M
Debt incl. finance leases $0.2M$0.2M$17.5Mβ€”β€”
Debt / equity 0.0x0.0x0.7xβ€”β€”
Interest coverage βˆ’52.5xβˆ’1,735.3xβˆ’21.6xβˆ’14.8xβˆ’8.3x
Current ratio 8.7x3.0x3.8x3.2x3.8x
Quick ratio 8.6x2.9x3.6x2.7x3.6x
Total assets $99.2M$68.7M$57.0M$30.1M$35.4M
Total liabilities $21.0M$26.7M$29.8M$15.7M$29.2M
Shareholders' equity $72.7M$37.9M$25.0M$13.6M$6.1M
Net debt (βˆ’ = net cash) βˆ’$80.0Mβˆ’$45.7Mβˆ’$17.0Mβ€”β€”

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Net income is positive βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ•
Cash from operations is positive βœ• βœ• βœ“ βœ• βœ• βœ• βœ• βœ• βœ• βœ•
Return on assets rose β€” βœ“ βœ“ βœ• βœ“ βœ“ βœ• βœ• βœ• βœ“
Cash from operations exceeds net income βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“
Debt fell relative to assets β€” β€” β€” β€” β€” βœ“ βœ• βœ• β€” β€”
Current ratio rose β€” βœ“ βœ• βœ“ βœ“ βœ• βœ• βœ“ βœ• βœ“
Share count didn't rise β€” βœ• βœ• βœ• βœ• β€” β€” βœ• βœ“ βœ•
Gross margin rose β€” β€” β€” β€” β€” β€” β€” β€” βœ“ βœ“
Revenue rose relative to assets β€” βœ• βœ“ βœ• βœ• β€” β€” β€” βœ“ βœ“
F-score β€” / 33 / 74 / 72 / 73 / 7β€” / 6β€” / 62 / 74 / 85 / 8
Accruals ratio βˆ’1,283.1%βˆ’227.8%βˆ’84.1%βˆ’25.5%βˆ’9.5%βˆ’28.7%βˆ’27.2%βˆ’6.7%βˆ’19.3%βˆ’46.2%
Altman Z'' βˆ’176.38βˆ’13.43βˆ’12.13βˆ’4.04βˆ’1.572.25βˆ’8.33βˆ’16.54βˆ’37.69βˆ’31.35

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Income statement
Revenue $1.4M $7.0M $7.7M $1.4M $0.9M β€” β€” $1.2M $3.7M $7.7M
Net interest income $1.4M $7.0M β€” β€” β€” β€” β€” β€” β€” β€”
Gross profit β€” β€” β€” β€” β€” β€” βˆ’$0.6M βˆ’$1.3M βˆ’$1.7M $0.3M
Research and development βˆ’$0.7M $4.4M $3.9M $10.6M $12.6M $11.8M $16.8M $24.4M $16.9M $10.2M
Operating income $2.3M βˆ’$11.1M βˆ’$3.1M βˆ’$18.1M βˆ’$22.2M βˆ’$40.7M βˆ’$52.1M βˆ’$63.0M βˆ’$44.5M βˆ’$29.0M
Interest expense $0.0M $0.0M $0.0M $0.0M $0.6M $0.8M $0.0M $2.9M $3.0M $3.5M
Pretax income $3.7M $18.0M βˆ’$6.6M βˆ’$20.1M βˆ’$22.9M βˆ’$44.1M βˆ’$59.4M βˆ’$64.3M βˆ’$48.5M βˆ’$34.3M
Income tax $0.0M β€” β€” βˆ’$0.2M β€” β€” β€” β€” β€” β€”
Net income βˆ’$3.7M βˆ’$18.0M βˆ’$6.6M βˆ’$19.9M βˆ’$22.9M βˆ’$43.2M βˆ’$55.8M βˆ’$60.2M βˆ’$46.6M βˆ’$33.2M
Net income to common βˆ’$3.9M βˆ’$18.0M βˆ’$6.6M βˆ’$20.5M βˆ’$22.5M β€” β€” β€” β€” β€”
Diluted EPS βˆ’$2.69 βˆ’$3.01 βˆ’$0.77 βˆ’$1.78 βˆ’$1.27 β€” βˆ’$1.86 βˆ’$1.82 βˆ’$13.77 βˆ’$4.01
Diluted shares 0.00B 0.01B 0.01B 0.01B 0.02B β€” 0.03B 0.03B 0.00B 0.01B
Cash flow
Cash from operations βˆ’$0.7M βˆ’$7.1M $1.3M βˆ’$15.3M βˆ’$19.6M βˆ’$23.1M βˆ’$33.0M βˆ’$56.0M βˆ’$38.2M βˆ’$18.1M
Capital expenditure βˆ’$0.0M $0.2M $0.1M $0.0M $0.9M $1.4M $3.9M $5.7M $5.9M $1.0M
Free cash flow βˆ’$0.7M βˆ’$7.4M $1.3M βˆ’$15.3M βˆ’$20.5M βˆ’$24.5M βˆ’$36.9M βˆ’$61.8M βˆ’$44.1M βˆ’$19.2M
Depreciation and amortization $0.0M $0.0M $0.1M $0.1M $0.2M $0.3M $0.6M $1.8M $3.0M $3.1M
Stock-based compensation $0.4M $4.4M $2.4M $3.6M $4.9M $7.8M $19.6M $21.3M $9.1M $5.3M
Share buybacks β€” $0.0M β€” β€” β€” β€” β€” β€” β€” β€”
Dividends and buybacks β€” $0.0M β€” β€” β€” β€” β€” β€” β€” β€”
Balance sheet
Cash and short-term investments $0.0M $9.0M $7.9M $19.8M $34.6M $80.2M $45.9M $34.5M $6.9M $11.6M
Total debt $0.0M β€” β€” β€” $4.5M $0.2M $0.2M $17.5M β€” β€”
Current assets $0.1M $9.1M $8.7M $26.7M $37.2M $92.9M $59.4M $43.9M $16.0M $24.8M
Current liabilities $2.0M $2.1M $5.4M $4.9M $3.8M $10.7M $19.8M $11.6M $5.0M $6.5M
Inventory β€” β€” β€” β€” β€” $0.4M $1.1M $2.1M $2.4M $1.4M
Property and equipment, net $0.1M $0.3M $0.2M $0.2M $0.9M $2.0M $5.0M $9.4M $11.0M $8.2M
Intangible assets β€” β€” β€” β€” $0.3M $1.8M $1.6M $1.4M $1.2M $1.0M
Total assets $0.2M $9.4M $9.4M $27.4M $40.5M $99.2M $68.7M $57.0M $30.1M $35.4M
Total liabilities $4.9M $5.7M $5.4M $9.3M $10.1M $21.0M $26.7M $29.8M $15.7M $29.2M
Shareholders' equity βˆ’$4.7M $1.5M $4.0M $18.1M $30.5M $72.7M $37.9M $25.0M $13.6M $6.1M
Margins
Gross margin β€” β€” β€” β€” β€” β€” β€” βˆ’112.8% βˆ’44.9% 3.3%
Operating margin 171.5% βˆ’158.6% βˆ’39.6% βˆ’1,305.1% βˆ’2,544.6% β€” β€” βˆ’5,436.2% βˆ’1,202.1% βˆ’378.2%
EBITDA margin 173.4% βˆ’158.1% βˆ’38.8% βˆ’1,299.5% βˆ’2,524.7% β€” β€” βˆ’5,280.9% βˆ’1,121.1% βˆ’337.9%
Net margin βˆ’273.5% βˆ’258.6% βˆ’84.9% βˆ’1,434.6% βˆ’2,620.3% β€” β€” βˆ’5,197.8% βˆ’1,258.4% βˆ’433.0%
FCF margin βˆ’50.7% βˆ’105.5% 16.6% βˆ’1,100.2% βˆ’2,351.5% β€” β€” βˆ’5,328.6% βˆ’1,190.3% βˆ’249.6%
Net interest share of revenue 100.0% 100.0% β€” β€” β€” β€” β€” β€” β€” β€”
Returns
Return on capital β€” β€” β€” β€” βˆ’5,753.8% β€” β€” βˆ’616.0% β€” β€”
Return on capital employed βˆ’129.4% βˆ’153.2% βˆ’76.0% βˆ’80.4% βˆ’60.5% βˆ’46.0% βˆ’106.3% βˆ’138.8% βˆ’177.7% βˆ’100.6%
Return on equity β€” β€” βˆ’235.5% βˆ’180.3% βˆ’94.2% βˆ’83.7% βˆ’100.9% βˆ’191.4% βˆ’241.4% βˆ’337.4%
Return on assets βˆ’1,576.3% βˆ’376.3% βˆ’69.8% βˆ’108.2% βˆ’67.3% βˆ’61.8% βˆ’66.5% βˆ’95.8% βˆ’107.2% βˆ’101.6%
Return on tangible equity β€” βˆ’1,165.9% βˆ’162.9% βˆ’113.1% βˆ’74.9% βˆ’60.9% βˆ’153.8% βˆ’255.0% βˆ’377.2% βˆ’650.9%
Growth
Revenue growth β€” 413.0% 10.7% βˆ’82.0% βˆ’37.2% β€” β€” β€” 219.7% 107.3%
FCF growth β€” β€” β€” βˆ’1,290.5% β€” β€” β€” β€” β€” β€”
Share count change β€” 314.4% 41.6% 35.4% 56.5% β€” β€” 10.6% βˆ’89.8% 145.2%
Financial health
Net debt / EBITDA 0.0x β€” β€” β€” β€” β€” β€” β€” β€” β€”
Debt / equity β€” β€” β€” β€” 0.1x 0.0x 0.0x 0.7x β€” β€”
Interest coverage 2,592.2x βˆ’742.8x βˆ’2,039.0x βˆ’594.8x βˆ’34.6x βˆ’52.5x βˆ’1,735.3x βˆ’21.6x βˆ’14.8x βˆ’8.3x
Current ratio 0.0x 4.3x 1.6x 5.5x 9.8x 8.7x 3.0x 3.8x 3.2x 3.8x
Quick ratio 0.0x 4.3x 1.6x 5.5x 9.8x 8.6x 2.9x 3.6x 2.7x 3.6x
Capital allocation
Capex / revenue βˆ’0.1% 3.5% 0.7% 3.1% 101.9% β€” β€” 495.7% 158.8% 13.3%
Stock comp / revenue 26.8% 62.8% 31.1% 257.4% 560.7% β€” β€” 1,841.0% 246.9% 68.8%
Quality scores
Piotroski F-score β€” 3.0 4.0 2.0 3.0 β€” β€” 2.0 4.0 5.0
Altman Z'' βˆ’176.4 βˆ’13.4 βˆ’12.1 βˆ’4.0 βˆ’1.6 2.3 βˆ’8.3 βˆ’16.5 βˆ’37.7 βˆ’31.4
Accruals ratio βˆ’1,283.1% βˆ’227.8% βˆ’84.1% βˆ’25.5% βˆ’9.5% βˆ’28.7% βˆ’27.2% βˆ’6.7% βˆ’19.3% βˆ’46.2%

Source: SEC EDGAR XBRL filings (CIK 0001641631). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open